Over the last few years, we have in-licensed a number of projects and opportunities from manufacturers and developers around the globe. Here is an overview of some of our current licenses and partnerships:
|
Â
| Company |
Compound |
Indication |
| Forest Laboratories, Inc. |
Escitalopram |
Depression |
| Teva Pharm. Industries Ltd. |
Rasagiline |
Parkinson's disease |
| Merz Pharmaceuticals |
Memantine |
Alzheimer's disease |
| PAION AG |
Desmoteplase |
Stroke |
| Solvay Pharmaceuticals B.V. |
Bifeprunox |
Schizophrenia |
| BioTie Therapies Corp. |
Nalmefene |
Alcohol dependence |
|
Neurim Pharmaceuticals Ltd.
|
Circadin
|
Primary Insomnia
|
|
Takeda Pharmaceutical Company Ltd.
|
LU AA21004
LU AA24530
|
Mood and anxiety disorders
|
Â
Â
|